mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.3 |